| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.900 | None | 0.982 | 1 | 1 | 1990 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
group | 0.700 | None | 1.000 | 1 | 1 | 1996 | 2016 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
group | 0.500 | None | 0.950 | 2 | 2 | 1999 | 2019 | ||||||||
|
endothelin 1 | 0.380 | 0.846 | 0.46 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2001 | 2019 | ||||||||
|
limbic system associated membrane protein | 0.558 | 0.654 | 0.99 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2001 | 2015 | ||||||||
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
group | 0.490 | None | 1.000 | 5 | 2 | 2002 | 2019 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2005 | 2016 | ||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
group | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
POU class 5 homeobox 1B | 0.670 | 0.346 | 2.9E-04 |
|
group | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | ||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
group | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
SMAD family member 7 | 0.470 | 0.769 | 0.55 |
|
group | 0.410 | None | 1.000 | 17 | 7 | 2007 | 2019 | ||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
group | 0.100 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
LDL receptor related protein 1 | 0.482 | 0.769 | 1.00 |
|
group | 0.110 | None | 1.000 | 2 | 2 | 2007 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily H member 1 | 0.542 | 0.731 | 0.55 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2007 | 2016 | ||||||||
|
colorectal cancer associated 1 | 0.780 | 0.154 |
|
group | 0.100 | None | 1.000 | 9 | 2 | 2008 | 2019 | |||||||||
|
colorectal cancer associated 2 | 0.769 | 0.154 | 0.75 |
|
group | 0.100 | None | 1.000 | 9 | 2 | 2008 | 2019 | ||||||||
|
rhophilin Rho GTPase binding protein 2 | 0.711 | 0.192 | 1.1E-07 |
|
group | 0.400 | None | 1.000 | 6 | 4 | 2008 | 2019 | ||||||||
|
gremlin 1, DAN family BMP antagonist | 0.508 | 0.808 | 0.47 |
|
group | 0.430 | None | 1.000 | 5 | 3 | 2008 | 2020 | ||||||||
|
Kruppel like factor 5 | 0.534 | 0.769 | 0.82 |
|
group | 0.410 | None | 1.000 | 2 | 1 | 2008 | 2019 | ||||||||
|
bone morphogenetic protein 4 | 0.422 | 0.808 | 0.96 |
|
group | 0.410 | None | 1.000 | 2 | 1 | 2008 | 2019 | ||||||||
|
cadherin 3 | 0.560 | 0.615 | 2.8E-10 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2008 | 2019 | ||||||||
|
laminin subunit alpha 5 | 0.636 | 0.577 | 6.5E-03 |
|
group | 0.100 | None | 1.000 | 3 | 2 | 2010 | 2019 | ||||||||
|
myeloid zinc finger 1 | 0.617 | 0.577 | 1.1E-10 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 2010 | 2019 | ||||||||
|
myoneurin | 0.722 | 0.423 | 0.57 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
vesicle transport through interaction with t-SNAREs 1A | 0.674 | 0.154 | 5.4E-04 |
|
group | 0.400 | None | 1.000 | 6 | 4 | 2011 | 2019 |